
GC41185
Magl-IN-1
Also listed as MAGL Inhibitor Compound 23
MAGL Inhibitor Compound 23 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM· MAGL Inhibitor Compound 23 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells· MAGL Inhibitor Compound 23 blocks MAGL in cell-based as well as in vivo assays
ChemicalCAS2324160-91-8MW369.4FormulaC22H24FNO3
- CAS number
- 2324160-91-8
- Molecular weight
- 369.4
- Formula
- C22H24FNO3
- Solubility
- DMF: 25 mg/ml,DMF:PBS (pH 7·2) (1:6): 0·14 mg/ml,DMSO: 20 mg/ml,Ethanol: 2·5 mg/ml
- InChIKey
- WUUBZNFATQKRPH-UHFFFAOYSA-N
- Catalogue number
- GC41185
- Brand
- GLPBIO
Computed properties PubChem CID 138319671 · XLogP 4.1 · TPSA 57.6 Ų · H-bond donors 1
- XLogP
- 4.1
- TPSA
- 57.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES CC(C)C1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=C(C=CC(=C3)O)F
Computed descriptors from PubChem (CID 138319671), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il